Cite
Jimenez-Fonseca P, Carmona-Bayonas A, Lamarca A, et al. External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study. Neuroendocrinology. 2021;112(1):88-100doi: 10.1159/000514808.
Jimenez-Fonseca, P., Carmona-Bayonas, A., Lamarca, A., Barriuso, J., Castaño, A., Benavent, M., Alonso, V., Riesco, M. D. C., Alonso-Gordoa, T., Custodio, A., Sanchez Canovas, M., Hernando, J., López, C., La Casta, A., Fernandez Montes, A., Marazuela, M., Crespo, G., Diaz, J. A., Feliciangeli, E., Gallego, J., Llanos, M., Segura, A., Vilardell, F., Percovich, J. C., Grande, E., Capdevila, J., Valle, J., & Garcia-Carbonero, R. (2022). External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study. Neuroendocrinology, 112(1), 88-100. https://doi.org/10.1159/000514808
Jimenez-Fonseca, Paula, et al. "External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study." Neuroendocrinology vol. 112,1 (2022): 88-100. doi: https://doi.org/10.1159/000514808
Jimenez-Fonseca P, Carmona-Bayonas A, Lamarca A, Barriuso J, Castaño A, Benavent M, Alonso V, Riesco MDC, Alonso-Gordoa T, Custodio A, Sanchez Canovas M, Hernando J, López C, La Casta A, Fernandez Montes A, Marazuela M, Crespo G, Diaz JA, Feliciangeli E, Gallego J, Llanos M, Segura A, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle J, Garcia-Carbonero R. External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study. Neuroendocrinology. 2022;112(1):88-100. doi: 10.1159/000514808. Epub 2021 Jan 28. PMID: 33508849.
Copy
Download .nbib